Loading...
Loading...
By Sofía Garduño - Tue, 11/25/2025 - 11:29
Healthcare stakeholders urge Mexico to reassess its IP strategy ahead of the USMCA review.
https://mexicobusiness.news/tag/anafam
More Health
By Sofía Garduño - Mon, 11/24/2025 - 10:26
ANAFAM outlines tariff, regulatory, and supply chain priorities as Mexico prepares its position for the 2026 USMCA review.
By Deyanira Chiñas - Mon, 07/04/2022 - 13:00
The Mexican pharma industry has not remained ‘asleep’ in the face of exclusions and bad decisions made by the government, writes Deyanira Chiñas.
By Miriam Bello - Wed, 08/19/2020 - 14:27
Yet another change in the Mexican healthcare sector amid a sanitary emergency. This time, it is COFEPRIS’ turn.
By Miriam Bello - Mon, 08/17/2020 - 14:19
Seven months in, INSABI has faced many challenges besides COVID-19. Here are some facts about the government’s venture toward universal healthcare.
By Miriam Bello - Wed, 07/15/2020 - 16:58
What does this decision mean for the local pharmaceutical industry and how are its representatives responding?
By Alicia Arizpe - Thu, 07/09/2020 - 20:28
As COVID-19 cases pile up, a growing number of researchers warn of the dangers of airborne transmission.
By Jan Hogewoning - Wed, 07/08/2020 - 09:47
President of ANFAM Cecilia Bravo explains the current challenges of medicine manufactures and the Association's work to overcome them
By - Fri, 09/20/2019 - 17:44
95 percent of medicines manufactured in Mexico are generics
By - Fri, 09/20/2019 - 17:35
Generics are always an attractive alternative for those who need medication at accessible prices, be they individuals or healthcare systems.
